Boettcher, Brian R.,Caplan, Shari L.,Daniels, Douglas S.,Hamamatsu, Norio,Licht, Stuart,Weldon, Stephen Craig
申请号：
AU2016202834
公开号：
AU2016202834A1
申请日:
2016.05.03
申请国别(地区):
AU
年份:
2016
代理人:
摘要：
#$%^&*AU2016202834A120160519.pdf#####H:Vc\Intrwovn\NRPortbl\DCC\REC\l0080520_I.docx-3/05/2016 ABSTRACT The invention relates to the identification of fusion proteins comprising polypeptide and protein variants of fibroblast growth factor 21 (FGF21) with improved pharmaceutical properties. Also disclosed are methods for treating FGF2 1-associated disorders, including metabolic conditions.
